A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy
- PMID: 27259757
- DOI: 10.1093/brain/aww133
A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy
Abstract
Limb girdle muscular dystrophy type 2A is the most common limb girdle muscular dystrophy form worldwide. Although strict recessive inheritance is assumed, patients carrying a single mutation in the calpain 3 gene (CAPN3) are reported. Such findings are commonly attributed to incomplete mutation screening. In this investigation, we report 37 individuals (age range: 21-85 years, 21 females and 16 males) from 10 families in whom only one mutation in CAPN3 could be identified; a 21-bp, in-frame deletion (c.643_663del21). This mutation co-segregated with evidence of muscle disease and autosomal dominant transmission in several generations. Evidence of muscle disease was indicated by muscle pain, muscle weakness and wasting, significant fat replacement of muscles on imaging, myopathic changes on muscle biopsy and loss of calpain 3 protein on western blotting. Thirty-one of 34 patients had elevated creatine kinase or myoglobin. Muscle weakness was generally milder than observed in limb girdle muscular dystrophy type 2A, but affected the same muscle groups (proximal leg, lumbar paraspinal and medial gastrocnemius muscles). In some cases, the weakness was severely disabling. The 21-bp deletion did not affect mRNA maturation. Calpain 3 expression in muscle, assessed by western blot, was below 15% of normal levels in the nine mutation carriers in whom this could be tested. Haplotype analysis in four families from three different countries suggests that the 21-bp deletion is a founder mutation. This study provides strong evidence that heterozygosity for the c.643_663del21 deletion in CAPN3 results in a dominantly inherited muscle disease. The normal expression of mutated mRNA and the severe loss of calpain 3 on western blotting, suggest a dominant negative effect with a loss-of-function mechanism affecting the calpain 3 homodimer. This renders patients deficient in calpain 3 as in limb girdle muscular dystrophy type 2A, albeit in a milder form in most cases. Based on findings in 10 families, our study indicates that a dominantly inherited pattern of calpainopathy exists, and should be considered in the diagnostic work-up and genetic counselling of patients with calpainopathy and single-allele aberrations in CAPN3.
Keywords: calpain 3; calpainopathy; dominant inheritance.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Comment in
-
Dominant LGMD2A: alternative diagnosis or hidden digenism?Brain. 2017 Feb;140(2):e7. doi: 10.1093/brain/aww281. Epub 2016 Nov 5. Brain. 2017. PMID: 27818383 No abstract available.
-
Reply: Dominant LGMD2A: alternative diagnosis or hidden digenism?Brain. 2017 Feb;140(2):e8. doi: 10.1093/brain/aww283. Epub 2016 Nov 15. Brain. 2017. PMID: 28137959 No abstract available.
Similar articles
-
Autosomal dominant calpainopathy due to heterozygous CAPN3 C.643_663del21.Muscle Nerve. 2018 Apr;57(4):679-683. doi: 10.1002/mus.25970. Epub 2017 Sep 30. Muscle Nerve. 2018. PMID: 28881388 Free PMC article.
-
Variants in CAPN3 Causing Autosomal Dominant Limb-Girdle Muscular Dystrophy Combined With Calpain-3 Deficiency.Hum Mutat. 2025 Mar 29;2025:9301465. doi: 10.1155/humu/9301465. eCollection 2025. Hum Mutat. 2025. PMID: 40226307 Free PMC article.
-
A single c.1715G>C calpain 3 gene variant causes dominant calpainopathy with loss of calpain 3 expression and activity.Hum Mutat. 2020 Sep;41(9):1507-1513. doi: 10.1002/humu.24066. Epub 2020 Jul 11. Hum Mutat. 2020. PMID: 32557990
-
Calpainopathy.2005 May 10 [updated 2025 May 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2005 May 10 [updated 2025 May 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301490 Free Books & Documents. Review.
-
Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A).Biochim Biophys Acta. 2007 Feb;1772(2):128-44. doi: 10.1016/j.bbadis.2006.07.002. Epub 2006 Jul 15. Biochim Biophys Acta. 2007. PMID: 16934440 Review.
Cited by
-
The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.Acta Neuropathol Commun. 2022 Feb 8;10(1):17. doi: 10.1186/s40478-022-01320-z. Acta Neuropathol Commun. 2022. PMID: 35135626 Free PMC article.
-
Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients.Ann Clin Transl Neurol. 2018 Dec 1;5(12):1574-1587. doi: 10.1002/acn3.649. eCollection 2018 Dec. Ann Clin Transl Neurol. 2018. PMID: 30564623 Free PMC article.
-
Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies.Ann Clin Transl Neurol. 2023 Nov;10(11):2092-2104. doi: 10.1002/acn3.51896. Epub 2023 Sep 8. Ann Clin Transl Neurol. 2023. PMID: 37688281 Free PMC article.
-
Targeted Next-Generation Sequencing Reveals Mutations in Non-coding Regions and Potential Regulatory Sequences of Calpain-3 Gene in Polish Limb-Girdle Muscular Dystrophy Patients.Front Neurosci. 2021 Oct 14;15:692482. doi: 10.3389/fnins.2021.692482. eCollection 2021. Front Neurosci. 2021. PMID: 34720847 Free PMC article.
-
Identification of a Novel Deep Intronic Mutation in CAPN3 Presenting a Promising Target for Therapeutic Splice Modulation.J Neuromuscul Dis. 2019;6(4):475-483. doi: 10.3233/JND-190414. J Neuromuscul Dis. 2019. PMID: 31498126 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases